Soleus Capital Management’s Akero Therapeutics AKRO Stock Holding History

Soleus Capital Management’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-71,000	Closed	-$3.37M	–	98
2025 Q3	$3.37M	Sell	71,000 -1,000	-1%	-$48.4K	0.17%	67
2025 Q2	$3.84M	Sell	72,000 -45,000	-38%	-$2.04M	0.25%	61
2025 Q1	$4.74M	Buy	+117,000	New	+$4.96M	0.34%	50

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Soleus Capital Management's AKRO Position: Q4 2025 in Review

Soleus Capital Management sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 71,000 shares — an estimated $3.37M sold.

Soleus Capital Management first reported a position in AKRO in Q1 2025 and held it in 3 quarters. The position peaked at $4.74M in Q1 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Soleus Capital Management reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Soleus Capital Management sold 71,000 Akero Therapeutics shares in Q4 2025, an estimated $3.37M.
Soleus Capital Management first reported a position in Akero Therapeutics in Q1 2025 and held it in 3 quarters.
Soleus Capital Management's Akero Therapeutics position peaked at $4.74M in Q1 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Soleus Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.